Revised Guide Clarifies Scope Of EMA Policy On Proactive Publication Of Clinical Data
Executive Summary
The European Medicines Agency has issued revised guidance to further clarify what information in regulatory submissions is covered by its policy on the proactive publication of clinical data. The updated guideline also addresses certain procedural issues to help companies submit proposed redactions.